Determining a Short Form Montreal Cognitive Assessment (s-MoCA) Czech Version: Validity in Mild Cognitive Impairment Parkinson’s Disease and Cross-Cultural Comparison
暂无分享,去创建一个
P. Moberg | R. Jech | T. Moore | D. Roalf | D. Weintraub | D. Wolk | M. Kopeček | O. Bezdicek | Markéta Červenková | Z. Šulc | Hana Stepankova Georgi
[1] P. Moberg,et al. Bridging cognitive screening tests in neurologic disorders: A crosswalk between the short Montreal Cognitive Assessment and Mini-Mental State Examination , 2017, Alzheimer's & Dementia.
[2] H. Štěpánková,et al. Montreal Cognitive Assessment and Mini‐Mental State Examination reliable change indices in healthy older adults , 2017, International journal of geriatric psychiatry.
[3] Marios Politis,et al. Cognitive decline in Parkinson disease , 2017, Nature Reviews Neurology.
[4] E. Růžička,et al. The Diagnostic Accuracy of Parkinson's Disease Mild Cognitive Impairment Battery Using the Movement Disorder Society Task Force Criteria , 2017, Movement disorders clinical practice.
[5] E. Růžička,et al. A parsimonious scoring and normative calculator for the Parkinson’s disease mild cognitive impairment battery , 2017, The Clinical neuropsychologist.
[6] T. Nikolai,et al. Montreal cognitive assessment (MoCA): Normative data for old and very old Czech adults , 2017, Applied neuropsychology. Adult.
[7] L. Wojtecki,et al. Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting , 2016, PloS one.
[8] Y. Ben-Shlomo,et al. Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson's Disease , 2016, Parkinson's disease.
[9] P. Moberg,et al. Defining and validating a short form Montreal Cognitive Assessment (s-MoCA) for use in neurodegenerative disease , 2016, Journal of Neurology, Neurosurgery & Psychiatry.
[10] H. Štěpánková,et al. Toward the processing speed theory of activities of daily living in healthy aging: normative data of the Functional Activities Questionnaire , 2016, Aging Clinical and Experimental Research.
[11] J. Trojanowski,et al. Longitudinal study of normal cognition in Parkinson disease , 2015, Neurology.
[12] M. Weiner,et al. An Abbreviated Montreal Cognitive Assessment (MoCA) for Dementia Screening , 2015, The Clinical neuropsychologist.
[13] R. Gur,et al. Development of an abbreviated form of the Penn Line Orientation Test using large samples and computerized adaptive test simulation. , 2015, Psychological assessment.
[14] M. Lamar,et al. Development, Validity, and Normative Data Study for the 12-Word Philadelphia Verbal Learning Test [czP(r)VLT-12] Among Older and Very Old Czech Adults , 2014, The Clinical neuropsychologist.
[15] J. Filoteo,et al. Instrumental activities of daily living are impaired in Parkinson's disease patients with mild cognitive impairment. , 2014, Neuropsychology.
[16] M. Jahanshahi,et al. Executive dysfunction in Parkinson's disease: a review. , 2013, Journal of neuropsychology.
[17] David R. Roalf,et al. Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging , 2013, Alzheimer's & Dementia.
[18] T. Robbins,et al. The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort , 2013, Journal of Neurology, Neurosurgery & Psychiatry.
[19] E. Růžička,et al. Czech version of the Trail Making Test: normative data and clinical utility. , 2012, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.
[20] R. Barker,et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines , 2012, Movement disorders : official journal of the Movement Disorder Society.
[21] M. Weiner,et al. Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample , 2011, Neurology.
[22] D. Aarsland,et al. The economic impact of cognitive impairment in Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.
[23] T. Anderson,et al. The MoCA , 2010, Neurology.
[24] A. Siderowf,et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease , 2009, Neurology.
[25] G. Pearlson,et al. Accounting for estimated IQ in neuropsychological test performance with regression-based techniques , 2009, Journal of the International Neuropsychological Society.
[26] S. Sawilowsky,et al. Impact of Rank-Based Normalizing Transformations on the Accuracy of Test Scores , 2009 .
[27] Seung W. Choi,et al. Firestar: Computerized Adaptive Testing Simulation Program for Polytomous Item Response Theory Models , 2009 .
[28] Daniel Weintraub,et al. Montreal Cognitive Assessment Performance in Patients with Parkinson's Disease with “Normal” Global Cognition According to Mini‐Mental State Examination Score , 2009, Journal of the American Geriatrics Society.
[29] C. Florkowski. Sensitivity, specificity, receiver-operating characteristic (ROC) curves and likelihood ratios: communicating the performance of diagnostic tests. , 2008, The Clinical biochemist. Reviews.
[30] Alberto L Fernández,et al. A comparison of normative data for the Trail Making Test from several countries: equivalence of norms and considerations for interpretation. , 2008, Scandinavian journal of psychology.
[31] Bernard Ravina,et al. The montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.
[32] J. Jankovic. Parkinson’s disease: clinical features and diagnosis , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[33] A. Lang,et al. A comparison of the mini mental state exam to the montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.
[34] E. Tolosa,et al. Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force , 2007, Movement disorders : official journal of the Movement Disorder Society.
[35] M. Boustani,et al. Dementia screening in primary care: is it time? , 2007, JAMA.
[36] E. Tolosa,et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.
[37] V. Calabrese,et al. PROJECTED NUMBER OF PEOPLE WITH PARKINSON DISEASE IN THE MOST POPULOUS NATIONS, 2005 THROUGH 2030 , 2007, Neurology.
[38] T. Robbins,et al. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. , 2007, Brain : a journal of neurology.
[39] C. Tanner,et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030 , 2007, Neurology.
[40] Tom Fawcett,et al. An introduction to ROC analysis , 2006, Pattern Recognit. Lett..
[41] J. Cummings,et al. The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.
[42] Günther Deuschl,et al. Rivastigmine for dementia associated with Parkinson's disease. , 2004, The New England journal of medicine.
[43] Norbert K Tanzer,et al. Bias and equivalence , 2000 .
[44] P. Fayers. Item Response Theory for Psychologists , 2004, Quality of Life Research.
[45] D. Aarsland,et al. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. , 2003, Archives of neurology.
[46] Marjan Jahanshahi,et al. What contributes to quality of life in patients with Parkinson's disease? , 2000, Journal of neurology, neurosurgery, and psychiatry.
[47] D. Aarsland,et al. Mental symptoms in Parkinson's disease are important contributors to caregiver distress , 1999, International journal of geriatric psychiatry.
[48] C. Marsden,et al. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. , 1992, Brain : a journal of neurology.
[49] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[50] E. DeLong,et al. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.
[51] A. Ardila,et al. Sociocultural effects in neuropsychological assessment. , 1985, The International journal of neuroscience.
[52] F. Lord. Applications of Item Response Theory To Practical Testing Problems , 1980 .
[53] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[54] F. Samejima. Estimation of latent ability using a response pattern of graded scores , 1968 .
[55] Louis Guttman,et al. A basis for analyzing test-retest reliability , 1945, Psychometrika.
[56] E. Růžička,et al. Validity of the Montreal Cognitive Assessment in the Detection of Mild Cognitive Impairment in Parkinson’s Disease , 2020 .
[57] O. Bezdíček,et al. Testy verbální fl uence , česká normativní studie pro osoby vyššího věku Tests of Verbal Fluency , Czech Normative Study in Older Patients , 2020 .
[58] D. Schretlen,et al. Sociocultural and Language Differences on the Trail Making Test , 2016 .
[59] David Magis,et al. Computerized adaptive testing , 2015 .
[60] J. Reban. MONTREALSKÝ KOGNITIVNÍ TEST (MoCA): PØÍNOS K DIAGNOSTICE PREDEMENCÍ , 2006 .
[61] H. Wainer. Computerized adaptive testing: A primer, 2nd ed. , 2000 .